All HHS Contracts — October 17, 2026

ATCC received a $91,580,433 obligation under a cost-plus-fixed-fee NIH/NIAID contract with $57,345,176 outlayed to date. The award signals continued federal funding for infectious disease research resources, but the recipient is a nonprofit with no identified public-company parent.

Only $91,580,433 of the $334,258,869 base-plus-options value is currently obligated, so roughly $242.7 million depends on future option exercises and annual appropriations at NIH/NIAID that are not guaranteed.

Continued option exercise on the ATCC BEI-RRP program would sustain research-services revenue tied to infectious disease resources, supporting a broader civilian life-sciences research demand thesis at NIH/NIAID.

The single award reflects continued NIH/NIAID funding for biological resources and emerging infections research, classified under NAICS 541715 and PSC AN12. Evidence is limited to one record, so no multi-year budget direction can be established from this data.

{"entity" => "American Type Culture Collection / NIH NIAID BEI-RRP", "reason" => "Only $91,580,433 of the $334,258,869 potential value is obligated and $57,345,176 is outlayed, so option exercise drives most remaining value; the recipient is nonprofit with no identified public-equity exposure.", "trigger" => "NIH/NIAID option exercise decisions and any modification to the 2027-10-15 current end date"}